
==== Front
Sao Paulo Med J
Sao Paulo Med J
Sao Paulo Med J
São Paulo Medical Journal
1516-3180
1806-9460
Associação Paulista de Medicina - APM

15692715
10.1590/S1516-31802004000600001
Editorial
New trends for anemia at the beginning of a new century…
Benseñor Isabela M. *
04 11 2004
2004
122 6 231232
https://creativecommons.org/licenses/by/4.0/ This is an open access article distributed under the terms of the Creative Commons license.
==== Body
pmcIn a recent article published in the Archives of Internal Medicine,1 the authors comment that "for too long, anemia has been viewed as an innocent bystander" in its frequent association with chronic diseases. How can we interpret anemia in Brazil, at this moment?

First, long-term time trends in Brazil, based on three cross-sectional studies conducted in the 1970s, 80s, and 90s, show us a rapid decline in the prevalence of childhood malnutrition and a rapid increase in adult overweight/obesity, but a high prevalence of anemia with a possible epidemic trend among children aged under five.2 Recent data suggest that the prevalence of anemia is increasing in all regions in the country, including richer and poorer areas, with the same burden. One possible cause for this, among children aged under two, is thought to be the large increase in milk consumption.3 Recent data on the prevalence of anemia among adults are more sparse: there are just two studies, from Pernambuco and Piauí, which simultaneously evaluated children and adults and found a nearly 25% prevalence of anemia among adults.4

Second, the diagnosis of anemia of moderate severity (9-13 g/dl) is very complicated because of our low perception of mild pallor at physical examination. Several data from the literature confirm this point.5-7 In Brazil, the reliability and validity of the presence of palmar and conjunctival pallor for anemia detection purposes have been evaluated by Spinelli et al.8 The results from comparing anemia diagnoses made by palmar and conjunctival examination with hemoglobin levels determined by blood cell count showed low levels of agreement. Conjunctival pallor was more sensitive than palmar pallor for diagnosing anemia. The authors concluded that it was still too early to recommend routine use of this technique without any kind of confirmation. Because of this difficulty in evaluating anemia in a clinical examination, several papers have discussed simple methods for diagnosing anemia in African countries where blood count tests are an impossibility. New strategies have been proposed, including hemoglobin color scales on which a drop of blood is compared by means of a plastic scale of red circles with the hemoglobin levels that these represent.6,9

Recent data have shown that quantifying anemia by choosing between four levels is a very imprecise method with no interobserver reliability. It is more correct to classify the grade of pallor as slight, moderate or severe or, better, as presence or absence of pallor.10 Such difficulty will be probably more intense for hemoglobin levels of 9-13 g/dl.

Recent data from Hospital das Clínicas, Faculdade de Medicina da Universidade de São Paulo, have shown that, out of 95 patients evaluated at an outpatient clinic, four diagnoses of anemia were made by physical examination. Of these 95 patients, and in addition to the four patients with anemia, another 31 patients were submitted to a complete blood count for various reasons other than anemia. Of the 35 complete blood counts, 11 showed anemia (the four diagnosed by physical examination and another seven for whom no pallor was observed during physical examination): one case of megaloblastic anemia, five cases of iron deficiency anemia and five cases of anemia associated with chronic disorders. All these patients had hemoglobin levels between 9 and 13 g/dl (Benseñor et al.; unpublished data).

The treatment of megaloblastic and iron deficiency anemia is very simple. However, for megaloblastic anemia, it needs to be determined whether the anemia is caused by a lack of folate or vitamin B12. For iron deficiency anemia, it needs to be determined whether blood loss is present, and one possible cause of this is colon cancer, which is frequently manifested by iron deficiency anemia.

And what about anemia that is associated with chronic disorders? The diagnoses are made but treatment is lacking. What is the problem here?

The problem is that there is now a lot of evidence suggesting that we cannot merely consider anemia to be an innocent bystander. Recent data has shown that anemia can interfere in the prognosis for chronic diseases such as heart failure and cancer, in the morbidity caused by these and other diseases and in the quality of life associated with these disorders. Mozaffarian et al.11 showed in a prospective, randomized study that anemia is a predictor for mortality in cases of severe heart failure. In a retrospective study of patients undergoing hemodialysis, hemoglobin levels of less than 8 g/dl were associated with a twofold increase in the probability of death, compared with patients with hemoglobin levels of more than 10 g/dl.12 An observational study has noted an association between hemoglobin levels of less than 10 g/dl and increased mortality rates among patients with cardiovascular disorders, thus suggesting low tolerance of anemia among such patients.13

Besides the impact on mortality, anemia can also influence morbidity. The treatment of anemia can improve left ventricular hypertrophy in patients with renal disease and it has a good effect on cognitive function and quality of life.14,15 In patients with heart failure, anemia treatment can improve symptoms and decrease the number of hospital days.16 Several trials are now testing the benefits of correcting anemia in patients with various types of cancer, based on the fact that for certain types of cancer, the presence of anemia can be associated with worse local and regional control and survival rates.17,18

Anemia can also have an impact on quality of life, as confirmed in several studies in which a questionnaire was applied to measure quality of life before anemia treatment and some months after treatment. Most of these studies have shown an improvement in quality of life, with hemoglobin levels of 8-14 g/dl.19,20

Thus, when we evaluate a patient in an outpatient clinic, it is now important to be sensitive towards mild cases of anemia. Perhaps we have to be less restrictive regarding complete blood cell counts precisely because we are not good enough at looking for mild pallor. This goes against what we learned at school but is perhaps more appropriate for borderline levels of anemia in this new century, with its new perception of quality of life. The other point is that our duty is not just to diagnose anemia, but also to investigate its possible causes and then to treat them.

Isabela M. Benseñor. Assistant professor in the Division of Clinical Medicine, Hospital das Clínicas, Universidade de São Paulo, São Paulo, Brazil. E-mail: isabensenor@hcnet.usp.br
==== Refs
REFERENCES

1 Nissenson AR Goodnough LT Dubois RW Anemia: not just an innocent bystander? Arch Intern Med 2003 163 12 1400 1404 12824088
2 Batista M Filho Rissin A A transição nutricional no Brasil: tendências regionais e temporais. [Nutritional transition in Brazil: geographic and temporal trends] Cad Saúde Pública 2003 19 Suppl 1 S181 S191 12886448
3 Levy-Costa RB Consumo de leite de vaca e anemia na infância no município de São Paulo [dissertation] São Paulo Faculdade de Saúde Pública da Universidade de São Paulo 2002
4 Santos LMP Bibliografia sobre deficiência de micronutrientes no Brasil, 1990-2000: Anemia Brasília Organização Pan-Americana da Saúde /Organização Mundial da Saúde 2002 Available from URL: http://www.opas.org.br/sistema/arquivos/pes_vol2a.pdfa Accessed in 2004 (Aug 17).
5 Sheth TN Choudhry NK Bowes M Detsky AS The relation of conjunctival pallor to the presence of anemia J Gen Intern Med 1997 12 2 102 106 9051559
6 Kalter HD Burnham G Kolstad PR Evaluation of clinical signs to diagnose anaemia in Uganda and Bangladesh, in areas with and without malaria Bull World Health Organ 1997 75 Suppl 1 103 111 9529723
7 Sanchez-Carrillo CI Bias due to conjunctiva hue and the clinical assessment of anemia J Clin Epidemiol 1989 42 8 751 754 2760666
8 Spinelli MGN Souza JMP Souza SB Sesoko EH Confiabilidade e validade da palidez palmar e de conjuntivas como triagem de anemia. [Reliability and validity of palmar and conjunctival pallor for anemia detection purposes] Rev Saúde Pública 2003 37 4 404 408 12937699
9 Lewis SM Stott GJ Wynn KJ An inexpensive and reliable new haemoglobin colour scale for assessing anaemia J Clin Pathol 1998 51 1 21 24 9577366
10 Drager LF Abe JM Martins MA Lotufo PA Bensenor IJ Impact of clinical experience on quantification of clinical signs at physical examination J Intern Med 2003 254 3 257 263 12930235
11 Mozaffarian D Nye R Levy WC Anemia predicts mortality in severe heart failure: the prospective randomized amlodipine survival evaluation (PRAISE) J Am Coll Cardiol 2003 41 11 1933 1939 12798560
12 Collins AJ Li S St Peter W Death, hospitalization, and economic associations among incident hemodialysis patients with hematocrit values of 36 to 39% J Am Soc Nephrol 2001 12 11 2465 2473 11675424
13 Carson JL Duff A Poses RM Effect of anaemia and cardiovascular disease on surgical mortality and morbidity Lancet 1996 348 9034 1055 1060 8874456
14 Besarab A Bolton WK Browne JK The effects of normal as compared with low hematocrit values in patients with cardiac disease who are receiving hemodialysis and epoetin N Engl J Med 1998 339 9 584 590 9718377
15 Levin A Thompson CR Ethier J Left ventricular mass index increase in early renal disease: impact of decline in hemoglobin Am J Kidney Dis 1999 34 1 125 134 10401026
16 Pickett JL Theberge DC Brown WS Schweitzer SU Nissenson AR Normalizing hematocrit in dialysis patients improves brain function Am J Kidney Dis 1999 33 6 1122 1130 10352201
17 Silverberg DS Wexler D Sheps D The effect of correction of mild anemia in severe, resistant congestive heart failure using subcutaneous erythropoietin and intravenous iron: a randomized controlled study J Am Coll Cardiol 2001 37 7 1775 1780 11401110
18 Fein DA Lee WR Hanlon AL Pretreatment hemoglobin level influences local control and survival of T1-T2 squamous cell carcinomas of the glottic larynx J Clin Oncol 1995 13 8 2077 2083 7636551
19 Glaspy J Bukowski R Steinberg D Taylor C Tchekmedyian S Vadhan-Raj S Impact of therapy with epoetin alfa on clinical outcomes in patients with nonmyeloid malignancies during cancer chemotherapy in community oncology practice. Procrit Study Group J Clin Oncol 1997 15 3 1218 1234 9060566
20 Demetri GD Kris M Wade J Degos L Cella D Quality-of-life benefit in chemotherapy patients treated with epoetin alfa is independent of disease response or tumor type: results from a prospective community oncology study. Procrit Study Group J Clin Oncol 1998 16 10 3412 3425 9779721
